Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiation Therapy in Reduced Dose and Hypofractionated Schedule After Trans-Oral Robotic Surgery in Intermediate Risk HPV-Mediated Oropharyngeal Squamous Cell Carcinoma

NCT07044635 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT07044635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07044635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiation Therapy in Reduced Dose and Hypofractionated Schedule After Trans-Oral Robotic Surgery in Intermediate Risk HPV-Mediated Oropharyngeal Squamous Cell Carcinoma
Lead sponsor
University of Utah
Phase
Phase 2
Overall status
Recruiting
Start date
July 23, 2025
Completion date
August 31, 2030
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hpv-mediated oropharyngeal squamous cell carcinoma, oropharyngeal squamous cell carcinoma